Stockreport

Molecular Partners Reports Highlights and Financial Results for Full Year 2025 [Yahoo! Finance]

Molecular Partners AG - American Depositary Shares  (MOLN) 
PDF Molecular Partners Initiated US Phase 1/2a study of DLL3-targeting Pb-based Radio-DARPin candidate MP0712 for SCLC and other neuroendocrine cancers, co-developed with [Read more]